Patent(s) and the Corresponding Patented Drug(s) |
Top |
United States Patent and Trademark Office (USPTO) |
Patent ID |
US8877260 |
Title |
Use of Acacia Extracts and Their Compounds On Inhibition of Xanthine Oxidase. |
Applicant(s) |
National Taiwan University |
Representative Drug(s) |
D0J0JH |
Drug Info
|
IC50 = 74 nM |
Click to Show More |
[1] |
2
|
D0S0EM
|
Drug Info
|
IC50 = 270 nM
|
[1] |
Patent ID |
US8729273 |
Title |
Compounds Effective Asxanthine Oxidase Inhibitors, Methods for Preparing The Same and Pharmaceutical Composition Containing The Same. |
Applicant(s) |
Lg Life Sciences Ltd |
Representative Drug(s) |
D0Z2IO |
Drug Info
|
IC50 = 2.1 nM |
Click to Show More |
[1] |
2
|
D0AJ5T
|
Drug Info
|
IC50 = 2.8 nM
|
[1] |
3
|
D0EZ5O
|
Drug Info
|
IC50 = 3.4 nM
|
[1] |
Patent ID |
US8414936 |
Title |
Use of Acacia Extracts and Their Compounds On Inhibition of Xanthine Oxidase. |
Applicant(s) |
National Taiwan University |
Representative Drug(s) |
D0J0JH |
Drug Info
|
IC50 = 74 nM |
Click to Show More |
[1] |
2
|
D0S0EM
|
Drug Info
|
IC50 = 270 nM
|
[1] |
Patent ID |
US0296537 |
Title |
Fused Heterocyclic Derivative and Pharmaceutical Use Thereof. |
Applicant(s) |
Kissei Pharmaceutical Co. Ltd |
Representative Drug(s) |
D08KAT |
Drug Info
|
IC50 = 10 nM |
Click to Show More |
[1] |
2
|
D0N0MV
|
Drug Info
|
IC50 = 10 nM
|
[1] |
3
|
D04BAQ
|
Drug Info
|
IC50 = 13 nM
|
[1] |
4
|
D0G9OT
|
Drug Info
|
IC50 = 13 nM
|
[1] |
5
|
D0RK3S
|
Drug Info
|
IC50 = 14 nM
|
[1] |
Patent ID |
US0289506 |
Title |
5-Membered Nitrogen Containing Heterocyclic Derivatives and Pharmaceutical Compositions Comprising The Same. |
Applicant(s) |
Kissei Pharmaceutical Co. Ltd |
Representative Drug(s) |
D0B5QZ |
Drug Info
|
IC50 = 1.7 nM |
Click to Show More |
[1] |
2
|
D0YX0S
|
Drug Info
|
IC50 = 3.3 nM
|
[1] |
3
|
D07TTT
|
Drug Info
|
IC50 = 5.2 nM
|
[1] |
4
|
D0QY4O
|
Drug Info
|
IC50 = 6.2 nM
|
[1] |
5
|
D0FM8Q
|
Drug Info
|
IC50 = 7.8 nM
|
[1] |
6
|
D0AU8E
|
Drug Info
|
IC50 = 52 nM
|
[1] |
Patent ID |
US0262567 |
Title |
Composition for Treating Gout, Containing Angelica Gigas Extract Having Xanthine Oxidase-Inhibiting Effect and An Inflammation Inducing Enzyme-Inhibiting Effect. |
Applicant(s) |
Korea Bio Health Co. Ltd |
Representative Drug(s) |
D04IGE |
Drug Info
|
IC50 = 18000 ng/ml |
Click to Show More |
[1] |
2
|
D0RN2X
|
Drug Info
|
IC50 = 18000 ng/ml
|
[1] |
Patent ID |
US0217878 |
Title |
(Aza)Indolizine Derivative and Pharmaceutical Use Thereof. |
Applicant(s) |
Kissei Pharmaceutical Co. Ltd |
Representative Drug(s) |
D0D6UT |
Drug Info
|
IC50 = 3 nM |
Click to Show More |
[1] |
2
|
D00GMJ
|
Drug Info
|
IC50 = 4 nM
|
[1] |
3
|
D0RK1R
|
Drug Info
|
IC50 = 4 nM
|
[1] |
4
|
D02VYR
|
Drug Info
|
IC50 = 5 nM
|
[1] |
5
|
D0J5GS
|
Drug Info
|
IC50 = 5 nM
|
[1] |
Patent ID |
US0201815 |
Title |
Fused Heterocyclic Derivative and Use Thereof for Medical Purposes. |
Applicant(s) |
Kissei Pharmaceutical Co. Ltd |
Representative Drug(s) |
D01FMW |
Drug Info
|
IC50 = 5 nM |
Click to Show More |
[1] |
2
|
D0AV1B
|
Drug Info
|
IC50 = 5 nM
|
[1] |
3
|
D03JDR
|
Drug Info
|
IC50 = 7 nM
|
[1] |
4
|
D0DQ6C
|
Drug Info
|
IC50 = 8 nM
|
[1] |
5
|
D0SY6J
|
Drug Info
|
IC50 = 8 nM
|
[1] |
6
|
D0NS7W
|
Drug Info
|
IC50 = 48 nM
|
[1] |
Patent ID |
US0189383 |
Title |
Use of Acacia Extracts and Their Compounds On Inhibition of Xanthine Oxidase. |
Applicant(s) |
National Taiwan University |
Representative Drug(s) |
D0J0JH |
Drug Info
|
IC50 = 74 nM |
Click to Show More |
[1] |
2
|
D0S0EM
|
Drug Info
|
IC50 = 270 nM
|
[1] |
Patent ID |
US8895626 |
Title |
Small Molecule Xanthine Oxidase Inhibitor and Methods of Use. |
Applicant(s) |
Baylor College of Medicine |
Representative Drug(s) |
D0LX9F |
Drug Info
|
IC50 = 3000 nM |
[1] |
Patent ID |
US8883858 |
Title |
Small Molecule Xanthine Oxidase Inhibitor and Methods of Use. |
Applicant(s) |
Baylor College of Medicine |
Representative Drug(s) |
D0LX9F |
Drug Info
|
IC50 = 3000 nM |
[1] |
Patent ID |
US8883857 |
Title |
Small Molecule Xanthine Oxidase Inhibitor and Methods of Use. |
Applicant(s) |
Baylor College of Medicine |
Representative Drug(s) |
D0LX9F |
Drug Info
|
IC50 = 3000 nM |
[1] |
Patent ID |
US0378552 |
Title |
Small Molecule Xanthine Oxidase Inhibitor and Methods of Use. |
Applicant(s) |
Baylor College of Medicine |
Representative Drug(s) |
D0LX9F |
Drug Info
|
IC50 = 3000 nM |
[1] |
Patent ID |
US0378478 |
Title |
Small Molecule Xanthine Oxidase Inhibitor and Methods of Use. |
Applicant(s) |
Baylor College of Medicine |
Representative Drug(s) |
D0LX9F |
Drug Info
|
IC50 = 3000 nM |
[1] |
Patent ID |
US0336204 |
Title |
Methods of Inhibiting Xanthine Oxidase Activity In A Cell. |
Applicant(s) |
Baylor College of Medicine |
Representative Drug(s) |
D0LX9F |
Drug Info
|
IC50 = 3000 nM |
[1] |
Patent ID |
US0329909 |
Title |
Small Molecule Xanthine Oxidase Inhibitor and Methods of Use. |
Applicant(s) |
Baylor College of Medicine |
Representative Drug(s) |
D0LX9F |
Drug Info
|
IC50 = 3000 nM |
[1] |
Patent ID |
US0281919 |
Title |
Agent for Treating or Preventing Digestive Ulcer. |
Applicant(s) |
Astellas Pharma Inc |
Representative Drug(s) |
D0GQ0V |
Drug Info
|
IC50 < 1 nM |
[1] |
Patent ID |
US005389 |
Title |
Small Molecule Xanthine Oxidase Inhibitor and Methods of Use. |
Applicant(s) |
Baylor College of Medicine |
Representative Drug(s) |
D0LX9F |
Drug Info
|
IC50 = 3000 nM |
[1] |
Patent ID |
US0004699 |
Title |
Small Molecule Xanthine Oxidase Inhibitor and Methods of Use. |
Applicant(s) |
Baylor College of Medicine |
Representative Drug(s) |
D0LX9F |
Drug Info
|
IC50 = 3000 nM |
[1] |
Patent ID |
US0165274 |
Title |
Xanthine Oxidase Inhibitor and Uric Acid Production Inhibitor. |
Applicant(s) |
Kao Cororation |
Canadian Intellectual Property Office (CIPO) |
Patent ID |
CA2897928 |
Title |
Azole Benzene Derivative. |
Applicant(s) |
Teizin Pharma Ltd |
Representative Drug(s) |
D06XJG |
Drug Info
|
IC50 < 5 nM |
Click to Show More |
[1] |
2
|
D0J3ZM
|
Drug Info
|
IC50 < 5 nM
|
[1] |
3
|
D0VY5N
|
Drug Info
|
IC50 < 5 nM
|
[1] |
4
|
D0XY7C
|
Drug Info
|
IC50 < 5 nM
|
[1] |
Patent ID |
CA2859099 |
Title |
Terminalia Chebula and Terminalia Bellerica Extracts for Inhibition of Xanthine Oxidase. |
Applicant(s) |
Natreon Inc |